Related Topics News -

     
 Title only   |   Print 
     
億騰嘉和主席擬斥最多100萬美元增持

2026-09-01T  
《盈警》億騰嘉和預告半年轉虧最少6,000萬人民幣

2026-08-23T  
億騰嘉和GB268 Ib/II期臨床試驗完成首例受試者給藥

2026-08-06T  
億騰嘉和擬於市場上購回股份

2026-07-08T  
億騰嘉和合作方Candid Therapeutics獲UCB提購

2026-05-04T  
《業績》億騰嘉和全年純利3.99億人幣升2.9% 不派息

2026-03-30T  
億騰嘉和終止兩項與納肽得siRNA資產合作安排

2026-03-03T  
億騰嘉和旗下EDP167 II期臨床試驗完成首例受試者給藥

2026-02-09T  
嘉和生物簡稱改「億騰嘉和」 本周五起生效

2026-02-04T  
嘉和生物擬根據授權購回股份

2026-01-22T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.